NASDAQ NMS - GLOBAL MARKET · CRVO
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
CervoMed Inc

CervoMed Inc

Biotechnology
$3.18
Card
Relationship Map

Follow $CRVO

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CRVO by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
CRVO
CervoMed Inc
Wed Oct 7 · last completed session · Markets closed · resumes Thu 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

51/ 100
Veridion Score
Middle range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Wed Oct 7 · last completed session · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CRVO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CRVO catalysts
About CervoMed Inc
PHARMACEUTICAL PREPARATIONS
Listed since
1996
Employees
15
Country
US

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.18
Last session
Day high
$3.18
Last session
Day low
$3.18
Last session
Previous close
$3.18
52W high
$9.94
-68.01% from high
52W low
$2.25
12% of range
Market cap
$50.5M
EPS
$-3.2106
Beta
2.28
Shares out
15.1M
Avg volume
208.8K
VWAP
$3.18
Last session
Price history computed in-house
1W
+8.53%
1M
+25.69%
3M
-10.92%
1Y
-64.27%
YTD
-59.75%
SMA 50 $2.69 · above
SMA 200 $3.98 · below
52W position 12%

CRVO overview

Veridion Score
51
Registered · 2026-10-07
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CRVO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CRVO Form 4 filings
Public disclosures

Congress activity in CRVO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

CRVO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CRVO in this window.
Lobbying spend

CRVO lobbying filings, year to date.

Registered lobbying filings matched to CervoMed Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CRVO in this window.
Loading news for CRVO
Analyst ratings
Sovereign unlock shows live analyst consensus for CRVO.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.